Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.
D000017:ABO Blood-Group System; D000328:Adult; D000373:Agglutinins / Q000032:analysis; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001652:Bile Ducts / Q000601:surgery*; D001658:Biliary Fistula / Q000517:prevention & control; D001707:Biopsy, Needle; D001787:Blood Group Incompatibility; D056486:Chemical and Drug Induced Liver Injury / Q000601:surgery*; D002648:Child; D002758:Cholangiography; D002761:Cholangitis / Q000517:prevention & control; D002779:Cholestasis / Q000517:prevention & control; D003601:Cytotoxicity Tests, Immunologic; D005704:Gallbladder / Q000601:surgery; D006084:Graft Rejection; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D007583:Jejunum / Q000601:surgery; D008103:Liver Cirrhosis / Q000601:surgery*; D016031:Liver Transplantation; D008875:Middle Aged; D014184:Transplantation, Homologous / Q000401:mortality
D000017:ABO Blood-Group System; D000373:Agglutinins; D000906:Antibodies; D007518:Isoantibodies